Latest filing published 14 Jun 2018 for Bellerophon Therapeutics, Inc., €21k.
Insider track record
Deborah Quinn: trading record in brief
All filings by Deborah Quinn on record concern Bellerophon Therapeutics, Inc. The record holds 6 filings, for trades running from 19 January 2016 to 12 June 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 14 June 2018, reports a share grant of €21k in Bellerophon Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Deborah Quinn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,541 shares@ US$2.3723.6% of flowCommon StockSEC:0001600132-18-000079:0
- 29,557 shares0Common StockSEC:0001600132-18-000017:0
- 33,114 shares@ US$2.4960.9% of flowCommon StockSEC:0001600132-18-000005:0
- 76,924 shares0Common StockSEC:0001600132-17-000032:0
- 18,548 shares@ US$1.3820.2% of flowCommon StockSEC:0001600132-16-000112:0
- 49,792 sharesCommon StockSEC:0001179110-16-017910:0
6 of 6 declarations